LSB LakeShore Biopharma: Rasio nilai perusahaan marang pendapatan

Logo perusahaan publik LakeShore Biopharma (LSB)

LakeShore Biopharma Co. (LSB) growth is based on the Chinese rabies vaccine market and R&D development. This EV/Sales chart illustrates the business value to revenue dynamics excluding debt, where the indicator reaches . However, corporate disputes and pricing pressure are eroding margins. High barriers to entry are ensured by strict GMP standards, patents, and lengthy clinical trials.

LSB YS Biopharma Co., Ltd.: Rasio nilai perusahaan marang pendapatan ing interval 04.07.2022 - 20.11.2026

LSB (LakeShore Biopharma Co., Ltd.): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:LSB, ysbiopharm.com
Produk seri LakeShore Biopharma

To filter out the risks of overpaying for an asset, it is necessary to analyze the ratio of Enterprise Value (EV) to annual sales. By tracking changes in the EV/Sales metric, an investor assesses the market value of the company, accounting for net debt relative to its revenue, which is critical during the expansion of the PIKA platform and the capture of Asian vaccine markets by LakeShore Biopharma Co. (LSB).